Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.08 +0.06 (+2.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Price to Book (2026)

Updated

Polaryx Therapeutics' Price to Book came in at 12.12 for Q2 2026, down 91.6% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Price to Book (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Polaryx Therapeutics 103.68 Mn 79.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.12
Mar 31, 2026 143.86
API Access

Polaryx Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=PLYX&period=max&api_key=YOUR_API_KEY